Skip to content
Recall Observatory FDA recall evidence

Drug product

Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC# 55566-6500-03

D-0879-2023

June 12, 2023

Class II

Product summary

Firm
Ferring Pharmaceuticals Inc
Event
Event 92494
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0879-2023

Official wording

Reason: cGMP deviations: potential for Microbial Contamination of Non-Sterile Products

Code information: AA200A, AA201A, Exp. 12/2025

Distribution pattern: USA Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP deviations
  • Microbial contamination

    reason.microbial_contamination · v1.0.0

    Microbial Contamination